
Quay Pharmaceuticals provides a comprehensive outsourcing service for the development and clinical manufacture of pharmaceutical products. Quay Pharma has particular expertise in the development of new chemical entities that exhibit poor solubility and bio-availability supporting their clients through to successful licensing deals.

- Pre-formulation
- Formulation development
- Analytical method development and contract analysis
(including stability testing to ICH guidelines) - Manufacture of clinical trial supplies
Quay is headed by Prof. Mike Rubinstein, who has over 30 years experience in pharmaceutical dosage form design, development and manufacturing.







